V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002941 | 210011427 | 1.72 | 85.1 | Adjuvant (A) | 2017-04-08 | 2017-08-05 | Docetaxel | null | N | DOCETAXEL | 100371653 |
| 210002943 | 210011428 | 1.5 | 66.6 | Adjuvant (A) | null | 2021-09-07 | Trastuzumab Subcutaneous | 01 | N | TRASTUZUMAB | 100086843 |
| 210002951 | 210011429 | null | 83.4 | null | null | 2017-10-03 | Trastuzumab | 02 | null | TRASTUZUMAB | 100080202 |
| 210002956 | 210011430 | 1.64 | 78.3 | null | 2017-06-27 | 2017-08-08 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100256975 |
| 210002959 | 210011432 | 1.57 | 70.9 | Adjuvant (A) | 2020-12-03 | 2021-01-01 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101277081 |
| 210002961 | 210011433 | 1.68 | 92.5 | Adjuvant (A) | null | 2017-10-16 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100315730 |
| 210002962 | 210011434 | 1.5 | 69.6 | Palliative (P) | null | 2018-02-01 | PACLITAXEL | null | N | PACLITAXEL | 100080286 |
| 210002976 | 210011436 | 1.77 | 79.3 | null | 2018-12-24 | 2019-05-05 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100655685 |
| 210002983 | 210011438 | 1.69 | 42.4 | Adjuvant (A) | 2020-11-16 | 2021-03-25 | Paclitaxel 7 day | null | N | PACLITAXEL | 100403952 |
| 210002984 | 210011439 | 1.74 | 72.4 | null | 2019-11-25 | 2019-12-11 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101104877 |
| 210002985 | 210011440 | 1.6 | 113.2 | Palliative (P) | 2019-05-25 | 2019-08-11 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100490388 |
| 210002986 | 210011441 | 1.53 | 84.4 | Neo-adjuvant (N) | 2021-09-04 | 2021-09-05 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101683041 |
| 210002990 | 210011442 | 1.71 | 0 | Adjuvant (A) | 2021-02-25 | 2021-03-08 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101808896 |
| 210002992 | 210011443 | 1.77 | 94.6 | Adjuvant (A) | 2019-01-17 | 2019-04-05 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101079367 |
| 210002998 | 210011446 | null | 93.8 | null | null | 2020-10-04 | Docetaxel | 02 | null | DOCETAXEL | 101435951 |
| 210002999 | 210011447 | 1.71 | 68.25 | Neo-adjuvant (N) | 2018-11-04 | 2018-11-07 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | PACLITAXEL | 101386322 |
| 210003000 | 210011448 | null | 69 | null | null | 2017-02-15 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101053721 |
| 210003001 | 210011449 | 1.65 | 76.65 | null | 2020-05-29 | 2020-08-15 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100250389 |
| 210003002 | 210011450 | 1.59 | 63.95 | null | 2019-07-17 | 2019-10-25 | Docetaxel | 02 | null | DOCETAXEL | 100825509 |
| 210003005 | 210011451 | 1.59 | 87 | Adjuvant (A) | 2018-01-23 | 2018-01-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100943216 |
| 210003008 | 210011454 | null | 57.3 | null | 2017-02-19 | 2017-03-22 | Docetaxel | 02 | N | DOCETAXEL | 101558070 |
| 210003016 | 210011456 | 1.57 | 86.4 | null | 2021-06-17 | 2021-09-11 | PACLITAXEL | 02 | N | PACLITAXEL | 100260629 |
| 210003028 | 210011459 | null | null | Palliative (P) | null | 2018-05-19 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101552841 |
| 210003029 | 210011460 | 1.62 | 54.2 | null | null | 2020-01-13 | Trastuzumab | null | null | TRASTUZUMAB | 100927096 |
| 210003031 | 210011461 | 1.63 | 85.8 | Neo-adjuvant (N) | 2017-06-06 | 2017-06-06 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100220188 |
| 210003034 | 210011462 | 1.68 | 108.5 | Neo-adjuvant (N) | null | 2020-01-15 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101051849 |
| 210003037 | 210011463 | 1.67 | 66.9 | Palliative (P) | 2019-08-05 | 2019-08-29 | Docetaxel | 02 | N | DOCETAXEL | 101449331 |
| 210003042 | 210011464 | 1.55 | 52.9 | null | 2020-07-21 | 2020-08-06 | Trastuzumab Subcutaneous | null | null | TRASTUZUMAB | 100806680 |
| 210003043 | 210011465 | 1.48 | 108.9 | null | 2019-04-06 | 2019-04-21 | PACLITAXEL | N | null | PACLITAXEL | 100052869 |
| 210003050 | 210011466 | 1.96 | 50.4 | Neo-adjuvant (N) | null | 2018-08-28 | Docetaxel | null | N | DOCETAXEL | 101216599 |
| 210003053 | 210011467 | 1.6 | 70 | Adjuvant (A) | null | 2021-05-04 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100836399 |
| 210003055 | 210011468 | 1.54 | 95 | Adjuvant (A) | null | 2017-07-25 | Docetaxel | 02 | N | DOCETAXEL | 101391093 |
| 210003057 | 210011469 | 1.6 | 68 | Adjuvant (A) | 2019-09-09 | 2019-12-03 | Docetaxel | 02 | N | DOCETAXEL | 100576686 |
| 210003059 | 210011470 | 1.72 | 85.2 | Adjuvant (A) | 2021-04-20 | 2021-07-16 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101512369 |
| 210003060 | 210011471 | null | null | Palliative (P) | null | 2016-06-21 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100109764 |
| 210003064 | 210011472 | null | 91 | Neo-adjuvant (N) | null | 2018-07-20 | Paclitaxel 7 day | null | N | PACLITAXEL | 101238725 |
| 210003067 | 210011474 | 1.71 | 64.2 | null | 2019-01-23 | 2019-04-18 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101080806 |
| 210003068 | 210011475 | 1.65 | 85 | null | null | 2019-03-06 | Docetaxel | N | null | DOCETAXEL | 100586804 |
| 210003070 | 210011476 | 1.6 | 92.8 | Palliative (P) | null | 2020-10-19 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100030471 |
| 210003071 | 210011477 | 1.64 | null | Adjuvant (A) | 2021-04-04 | 2021-07-08 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100420339 |
| 210003072 | 210011478 | 1.58 | 91.8 | Adjuvant (A) | 2019-11-20 | 2019-11-21 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100458010 |
| 210003074 | 210011479 | 1.57 | 61.2 | Adjuvant (A) | null | 2020-01-22 | Docetaxel | null | N | DOCETAXEL | 101289124 |
| 210003081 | 210011480 | 1.54 | 68.25 | Adjuvant (A) | null | 2022-05-01 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 101022581 |
| 210003088 | 210011481 | 1.67 | 56 | Neo-adjuvant (N) | null | 2017-08-03 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100999924 |
| 210003090 | 210011482 | 1.63 | null | Neo-adjuvant (N) | 2020-05-24 | 2020-06-03 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100973773 |
| 210003091 | 210011483 | null | null | Adjuvant (A) | 2020-04-09 | 2020-09-12 | CYCLOPHOSPHAMIDE + EPIRUBICIN | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100129135 |
| 210003092 | 210011484 | 1.68 | 83.5 | Adjuvant (A) | 2019-07-18 | 2019-08-05 | Paclitaxel 7 day | null | N | PACLITAXEL | 101342059 |
| 210003100 | 210011487 | 1.65 | 73.7 | Curative (C) | 2017-10-02 | 2017-10-08 | Paclitaxel 7 day | N | N | PACLITAXEL | 100674209 |
| 210003101 | 210011488 | 1.66 | 92.4 | Adjuvant (A) | 2020-11-22 | 2021-04-01 | Trastuzumab | null | N | TRASTUZUMAB | 100956743 |
| 210003103 | 210011489 | 1.72 | 84 | Adjuvant (A) | 2018-06-18 | 2018-06-18 | Docetaxel | null | N | DOCETAXEL | 101489039 |